Literature DB >> 29466150

Nonalcoholic Steatohepatitis.

.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29466150     DOI： 10.1056/NEJMc1716786

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Serum miR-33a is associated with steatosis and inflammation in patients with non-alcoholic fatty liver disease after liver transplantation.

Authors:  Denisa Erhartova; Monika Cahova; Helena Dankova; Marie Heczkova; Irena Mikova; Eva Sticova; Julius Spicak; Ondrej Seda; Pavel Trunecka
Journal:  PLoS One       Date:  2019-11-08       Impact factor: 3.240

Review 2.  History of Nonalcoholic Fatty Liver Disease.

Authors:  Amedeo Lonardo; Simona Leoni; Khalid A Alswat; Yasser Fouad
Journal:  Int J Mol Sci       Date:  2020-08-16       Impact factor: 5.923

3.  Analyzing human knockouts to validate GPR151 as a therapeutic target for reduction of body mass index.

Authors:  Allan Gurtan; John Dominy; Shareef Khalid; Linh Vong; Shari Caplan; Treeve Currie; Sean Richards; Lindsey Lamarche; Daniel Denning; Diana Shpektor; Anastasia Gurinovich; Asif Rasheed; Shahid Hameed; Subhan Saeed; Imran Saleem; Anjum Jalal; Shahid Abbas; Raffat Sultana; Syed Zahed Rasheed; Fazal-Ur-Rehman Memon; Nabi Shah; Mohammad Ishaq; Amit V Khera; John Danesh; Philippe Frossard; Danish Saleheen
Journal:  PLoS Genet       Date:  2022-04-05       Impact factor: 5.917

4.  Targeting the Cholecystokinin Receptor: A Novel Approach for Treatment and Prevention of Hepatocellular Cancer.

Authors:  Martha D Gay; Anita Safronenka; Hong Cao; Felice H Liu; Zoe X Malchiodi; Robin D Tucker; Alexander Kroemer; Narayan Shivapurkar; Jill P Smith
Journal:  Cancer Prev Res (Phila)       Date:  2020-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.